Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol dose-escalation in previously treated CLL/SLL
NCT00058240Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2003
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström macroglobulinemia (WM), sponsored by National Cancer Institute. Started Apr 2003; status: completed.
02
Drugs
alvocidib
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)Waldenström macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00058240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058240.